Prucalopride
Links shared publicly online about this topic
NICE Recommends Prucalopride For Chronic Constipation In Women
medicalnewstoday.com — “In final guidance published yesterday, NICE recommends prucalopride (Resolor, Movetis) as a treatment option for some women with chronic constipation in whom laxatives have not provided adequate r” View full resource at medicalnewstoday.com
Most Recently Shared on December 16, 2010 at 12:30 pm By:
Debby Verville Health Advocate
NICE Recommends Prucalopride For Chronic Constipation In Women: In final guidance published yesterday, NICE reco... http://mnt.to/f/3P84
Draft NICE Guidance Recommends Prucalopride For Chronic Constipation In Women
medicalnewstoday.com — “In draft guidance published, NICE recommends prucalopride (Resolor, Movetis) as an option f” View full resource at medicalnewstoday.com
Most Recently Shared on October 24, 2010 at 12:05 pm By:
MNT Gastrointestinal Health News
Draft NICE Guidance Recommends Prucalopride For Chronic Constipation In Women http://mnt.to/3LDh #gastrointestinal
PharmaLive: Shire Acquires US Rights to Resolor (prucalopride)
pharmalive.com — “PharmaLive: Shire Acquires US Rights to Resolor (prucalopride)” View full resource at pharmalive.com
Most Recently Shared on January 10, 2012 at 3:00 pm By:
PharmaLive Pharma and Health News
#Shire Acquires US Rights to Resolor (prucalopride): http://t.co/lDLHL84C
NHS Evidence - Gastroenterology and liver diseases - Prucalopride for the treatment of chronic constipation in women
library.nhs.uk — “Aims: This guidance addresses the use of prucalopride as a possible treatment for women with chronic constipation. Recommendations: Prucalopride is recommended as an option for the treatment of chronic constipation only in women for whom treatment with at least two laxatives from different classes, at the highest tolerated recommended doses for at least 6 months, has failed to provide adequate relief and invasive treatment for constipation is being considered. If treatment with prucalopride is n” View full resource at library.nhs.uk
Most Recently Shared on January 7, 2011 at 1:23 am By:
Prucalopride for the treatment of chronic constipation in women: Aims: This guidance addresses the use of prucal... http://bit.ly/fcY9q1
Movetis Starts Phase III Clinical Trial With Prucalopride In Male Patients With Chronic Constipation
medicalnewstoday.com — “Movetis NV (MOVE), the European gastrointestinal (GI) speciality pharmaceutical company, announces that it has started a phase III clinical trial with prucalopride in male patients with chronic co” View full resource at medicalnewstoday.com
Most Recently Shared on September 25, 2010 at 2:05 pm By:
MNT Gastrointestinal Health News
Movetis Starts Phase III Clinical Trial With Prucalopride In Male Patients With Chronic Constipation http://mnt.to/3KmT #gastrointestinal
Gastro Medical News about Constipation Analgesics, Opioid Opioid-Related Disorders Prucalopride
mdlinx.com — “Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Constipation” View full resource at mdlinx.com
Most Recently Shared on May 4, 2010 at 12:54 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and Safety of Prucalopride in Patients with Chronic Noncancer Pain Suffering from Opioid-Induced Const... http://bit.ly/901hGZ #GI
Movetis Starts Phase III Clinical Trial With Prucalopride In Male Patients With Chronic Constipation - QualityPoint Technologies
qualitypointtech.net — “Movetis NV (MOVE), the European gastrointestinal (GI) speciality pharmaceutical company, announces that it has started a phase III clinical trial with prucalopride in male patients with chronic constipation. Positive results from this clinical trial programme should allow Movetis to support a regulatory application for expansion of the current label of Resolor (prucalopride)(1). Approval of the regulatory application by the registration authorities would enable physicians to prescribe this medic” View full resource at qualitypointtech.net
Most Recently Shared on September 26, 2010 at 7:00 am By:
Movetis Starts Phase III Clinical Trial With Prucalopride In Male Patients With Chronic Constipation: Movetis NV (... http://bit.ly/9W98yJ
A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation - Müller-lissner - 2010 - Neurogastroenterology & Motility - Wiley Online Library
onlinelibrary.wiley.com — “A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation - Müller-lissner - 2010 - Neurogastroenterology & Motility - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on August 11, 2010 at 11:09 am By:
A doubleâ€*blind, placeboâ€*controlled study of prucalopride in elderly patients with chronic constipation: Abstra... http://bit.ly/b5EURY
Gastro Medical News about Constipation
mdlinx.com — “Prucalopride: a guide to its use in chronic constipation” View full resource at mdlinx.com
Most Recently Shared on May 20, 2010 at 11:59 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Prucalopride: a guide to its use in chronic constipation: Drugs & Therapy Perspectives http://bit.ly/cekIlu #GI
NICE recommends constipation drug | GP online
gponline.com — “GPs will have access to a greater variety of treatment options for chronic constipation after NICE approved the drug prucalopride.” View full resource at gponline.com
Most Recently Shared on December 20, 2010 at 12:13 pm By:
GPonline.com Medical Education and Medical Publisher
Latest news: NICE recommends constipation drug prucalopride http://bit.ly/h41UKY
Gastro Medical News about Constipation
mdlinx.com — “A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation” View full resource at mdlinx.com
Most Recently Shared on June 9, 2010 at 11:46 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation: Neuroga... http://bit.ly/dq3RSs #GI
New treatment for chronic constipation in women | News | Nursing Times
nursingtimes.net — “Prucalopride (Resolor, Movetis) should be an option for the treatment of chronic constipation in women.” View full resource at nursingtimes.net
Most Recently Shared on November 1, 2010 at 12:53 am By:
News: New treatment for chronic constipation in women http://bit.ly/buyE9z
NICE releases draft guidance on constipation in women | News | Nursing Times
nursingtimes.net — “NICE has published draft guidance recommending prucalopride (Resolor, Movetis) as an option for the treatment of chronic constipation in women.” View full resource at nursingtimes.net
Most Recently Shared on August 9, 2010 at 6:04 am By:
News: NICE releases draft guidance on constipation in women http://bit.ly/asV5cY
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Debby Verville
Writer for numerous companies including: www.tubal-reversal.net/
-
MNT Gastrointestinal
The latest gastrointestinal news published daily. Articles from research centers, universities and prestigious journals.
-
PharmaLive
Advertisement
